TM Publications 1996 - 2000

 

General

  1. Barbara JA. Chapter 25: Prevention. Viral Hepatitis, (2nd Ed) 1998. Editors: Zuckerman AJ, Thomas HC. Publishers: Churchill Livingstone 347-358.
  2. Barbara JA. NAT: perspectives for cellular components. Biologicals 1999; 27, 333-336.

Back to top

 

Transfusion Microbiology

  1. Barbara JA. Prevention of infections transmissible by blood derivatives. Transfusion Science 1998; 19(1):3-7.
  2. Voak D, Caffrey EA, Barbara JA, Pollack A, Scott M, Contreras MC. Affordable safety for the blood supply in developed and developing countries. Transfusion Medicine 1998; 8:73-76.
  3. Reesink HW, Engelfreit CP, Vrielink H, Krusius T, Lankinen M, Flanagan P, Barbara J, Gill P, Dodd RY, Busch MP, Prati D, Mozzi F, Sirchia G, Diekamp U, Epstein JS, Tabor E, Martin-Vega C, Hernandez JM. Consequences of nucleic acid amplification testing for blood transfusion centres. Vox Sanguinis 1998; 74: 263-270.
  4. Barbara JA. Microbial safety of blood transfusion. Vox Sanguinis 1998; 74 Suppl 2: 11-13.
  5. Warwick RM, Barbara JA. Safety aspects of cord blood banking. Bone Marrow Transplantation 1998; 21 Suppl 3; S40-42.
  6. James V, Hewitt PE, Barbara JA. How understanding donor behavior should shape donor selection. Transfusion Medicine Reviews 1999; 131: 49-64.
  7. Petrik J, Hewitt P, Barbara J, Allain J-P. Large-scale HCV RNA screening in first-time blood donors: the first step towards genomic screening of blood donations. Vox Sanguinis 1999; 76: 159-162.
  8. Pamphilon DH, Rider JR, Barbara JA, Williamson LM. Prevention of transfusion-transmitted cytomegalovirus infection. Transfusion Medicine 1999; 9:115-123.
  9. Flanagan P, Barbara JA. PCR testing of plasma pools: from concept to reality. Transfusion Medicine Reviews 1999; 13: 164-176.
  10. Whitby KP, Garson JA, Barbara JA. Polymerase chain reaction and transfusion-related infections. Chapter 38: Scientific Basis of transfusion Medicine 1999; Editors: Anderson KC, Ness PM. Publishers: WB Saunders: 542-552.
  11. McDonald CP, Cook R, Engel A, Robbins S, Rayfield I, Barbara JAJ. Robotic selective sampling and total automation for anti-CMV screening. Transfusion Medicine 1999; 9, 301-305.
  12. Barbara JAJ. Experiences with genetic screening for established and new agents. Advances in Transfusion Safety. Developments in Biologicals 1999; 102,99-103.
  13. Warwick RM, Barbara JA. Reducing the risks of disease transmission in cord blood transplantation. In Cord Blood Characteristics: Role in Stem Cell Transplantation (2000): Cord Blood Donor Selection 1999 Editors Shara B A Cohen, Elaine Gluckman, Pablo Rubinstein, JA Madrigal. Chapter 7: Publisher: M. Dunitz, Lond. UK. 149-167.
  14. Barbara J. Prions and blood transfusion. Transfusion Science 2000; 22:49
  15. Barbara JAJ. Infections and blood transfusion. Advances in Haematology, 32nd Annual Course. Imperial College School of Medicine, University of London, Hammersmith 19th -23rd June 2000:21-24.
  16. Kitchen AD, Barbara JA. Which agents threaten blood safety in the future? Baillieres Best Pract Res Clin Haematol. 2000 Dec;13:601-614.
  17. Caspari G, Barbara JA. Anti-HEV in blood donors: what is test and what is virus? Vox Sanguinis. 2000;78:198-9.
  18. Grant PR, Kitchen A, Barbara JA, Hewitt P, Sims CM, Garson JA, Tedder RS. Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice. Vox Sanguinis. 2000;78:137-42.
  19. Price J, Cant BA, Barbara JA, Tedder RS. Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populations. Vox Sanguinis. 2001;80(3):148-50.
  20. Barbara JAJ. Surrogate tests. Vox Sanguinis 2000 78(suppl 2): 63-65
  21. Barbara J, Galea G, Warwick R. Prevalence of HIV and hepatitis C markers among a cadaveric population in Milan. Journal of Clinical Pathology 2000; 53(5):405.
  22. Barbara JAJ. Transfusion transmitted infections. Tumori 2001 87:S8-10.
  23. Caspari G, Barbara JA. Anti-HEV in blood donors: what is test and what is virus? Vox Sanguinis. 2000;78(3):198-9.
  24. Barbara J, Moore MC, Hewitt PE. Prevalence of antibodies to HTLV in blood donors in North London. British Medical Journal. 2000 4;320(7235):650.

Back to top


Bacteriology

  1. McDonald CP, Hartley S, Orchard K, Hughes G, Brett MM, Hewitt PE, Barbara JA. Fatal clostridium perfringens sepsis from a pooled platelet transfusion. Transfusion Medicine 1998; 8:19-22.

Back to top


Surveillance and Epidemiology

  1. Soldan K, Barbara JA. Were collaborative authors on Transfusion-Transmitted Infections Chapter 13: of the Annual Report of the SHOT (serious hazards of transfusion) Committee. 1997-1998; The Serious Hazards of Transfusion Scheme, 69-76.
  2. Barbara J, Flanagan P. Blood transfusion risk : protecting against the unknown. British Medical Journal 1998; 316:717-718.
  3. Soldan K, Barbara JA, Heptonstall, J. Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-95. British Medical Journal 1998; 316: 1413-1417. Kitchen A
  4. Soldan K, Barbara JA. Estimation of the infectious risks of blood transfusion. Hematology 1998; 3: 333-338.
  5. Love EM, Jones H, Williamson LM, Cohen H, Todd A, Soldan K, Revill J, Norfolk DR, Barbara JA, Atterbury CLJ, Asher D. The Annual Report of the SHOT (serious hazards of transfusion) Committee.1998-1999; Manchester: SHOT.
  6. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. British Medical Journal 1999; 319: 16-19.
  7. Soldan K, Barbara J. The risks of infection transmission by blood transfusion in England. Journal of Clinical Pathology 1999; 52: 405-408.
  8. Regan FAM, Hewitt PE, Barbara JA, Contreras M. Prevalence of undiagnosed hepatitis B and C, HIV and HTLV infection in hospital in-patients. Journal of Infection 1999; 39, 168-169.
  9. Regan FA, Hewitt PE, Barbara JA, Contreras M. Prospective investigation of transfusion transmitted infection in the recipients of over 20,000 units of blood. British Medical Journal 1999; 320,403-406.
  10. Regan FAM, Hewitt PE, Barbara JAJ, Contreras M. Prevalence of undiagnosed hepatitis B and C, HIV and HTLV infections in hospital in-patients. Journal of Infection 1999; 39,168-169.
  11. Soldan K, Barbara JAJ, Slopecki A, Robinson A. Bacterial contamination of blood components. International Forum Edited by Engelfreit CP, Reesink HW. Vox Sanguinis 2000;78:59-67.
  12. Howell DR, Webster MH, Barbara JAJ. Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies. Transfusion Medicine 2000;10:265-269.
  13. Whitby K, Ferns RB, Garson JA, Bailey M, Howell D, Barbara JA, Tedder RS. GBV-C prevalence in blood donors and transfusion recipients in South East England. Vox Sanguinis 2000;79:246.
  14. Stanworth SJ, Warwick RM, Ferguson M, Barbara JA. A UK survey of virological testing of cadaver tissue donors. Microbiology Working Group of the NIBSC steering group on Tissue/Cell Banking and Engineering. Vox Sanguinis. 2000;79:227-30.
  15. Howell DR, Webster MH, Barbara JA. Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies. Transfusion Medicine. 2000 Dec;10:265-9.
  16. Love EM, Jones H, Williamson LM, Cohen H, Todd A, Soldan K, Revill J, Norfolk DR, Barbara JA, Atterbury CLJ, Asher D. The Annual Report of the SHOT (serious hazards of transfusion) Committee.1999-2000; Manchester: SHOT.

Back to top

Also see